Inari Medical, Inc. NARI
Trading inactive
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Richard Newitter | Truist Financial | 55.03 $ | 63 $ | 7.97 % | 18/12/2024 |
| David Rescott | Robert W. Baird | 49.27 $ | 67 $ | 17.73 % | 29/10/2024 |
| Adam Maeder | Piper Sandler | 42.56 $ | 52 $ | 9.44 % | 29/10/2024 |
| William Plovanic | Canaccord Genuity | 42.56 $ | 74 $ | 31.44 % | 29/10/2024 |
| Richard Newitter | Truist Financial | 42.56 $ | 50 $ | 7.44 % | 29/10/2024 |
| Marie Thibault | BTIG | 42.56 $ | 86 $ | 43.44 % | 29/10/2024 |
| David Rescott | Robert W. Baird | 42.2 $ | 66 $ | 23.80 % | 15/10/2024 |
| Mathew Blackman | Stifel Nicolaus | 44.1 $ | 50 $ | 5.90 % | 17/09/2024 |
| Pito Chickering | Deutsche Bank | 48.72 $ | 68 $ | 19.28 % | 09/08/2024 |
| David Rescott | Robert W. Baird | 52.11 $ | 63 $ | 10.89 % | 31/07/2024 |
| Larry Biegelsen | Wells Fargo | 52.11 $ | 65 $ | 12.89 % | 31/07/2024 |
| Richard Newitter | Truist Financial | 54.97 $ | 60 $ | 5.03 % | 16/07/2024 |
| Adam Maeder | Piper Sandler | 44.3 $ | 50 $ | 5.70 % | 01/05/2024 |